These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12639220)

  • 1. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.
    Deakin S; Guernier S; James RW
    Pharmacogenet Genomics; 2007 Jun; 17(6):451-7. PubMed ID: 17502837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.
    Ikeda Y; Suehiro T; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2008 Dec; 57(12):1725-32. PubMed ID: 19013297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
    Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
    Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells.
    Luk JM; Tong MK; Mok BW; Tam PC; Yeung WS; Lee KF
    FEBS Lett; 2004 Dec; 578(3):251-6. PubMed ID: 15589828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
    Laenen K; Haegeman G; Vanhoenacker P
    Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of human UDP-glucose dehydrogenase gene promoter: identification of an Sp1 binding site crucial for the expression of the large transcript.
    Vatsyayan J; Peng HL; Chang HY
    J Biochem; 2005 Jun; 137(6):703-9. PubMed ID: 16002992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate regulation of bovine prion protein gene promoter activity by two Sp1 binding site polymorphisms.
    Xue G; Sakudo A; Kim CK; Onodera T
    Biochem Biophys Res Commun; 2008 Aug; 372(4):530-5. PubMed ID: 18505676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
    Liu W; Innocenti F; Wu MH; Desai AA; Dolan ME; Cook EH; Ratain MJ
    Cancer Res; 2005 Jan; 65(1):46-53. PubMed ID: 15665278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
    Najafi M; Gohari LH; Firoozrai M
    Thromb Res; 2009; 123(3):503-10. PubMed ID: 18433845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
    Yan Y; Dalmasso G; Sitaraman S; Merlin D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.
    Jun DY; Park HS; Lee JY; Baek JY; Park HK; Fukui K; Kim YH
    Gene; 2008 May; 414(1-2):106-14. PubMed ID: 18378410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
    Liu J; Yang H; Liu W; Cao X; Feng X
    J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.